Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-057370
Filing Date
2023-05-09
Accepted
2023-05-08 21:09:18
Documents
4
Period of Report
2023-05-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2314728d1_pre14a.htm PRE 14A 659772
2 GRAPHIC tm2314728d1_pre14aimg01.jpg GRAPHIC 4662
3 GRAPHIC tm2314728d1_pre14aimg02.jpg GRAPHIC 376783
4 GRAPHIC tm2314728d1_pre14aimg03.jpg GRAPHIC 489978
  Complete submission text file 0001104659-23-057370.txt   1861608
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40598 | Film No.: 23899677
SIC: 2836 Biological Products, (No Diagnostic Substances)